According to the new market research report "Drug Screening Market by Product (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period.
Drug screening is an important part of the healthcare industry, as it is a key factor in preventing health risks and ensuring the safety of the public. With the increasing prevalence of drug abuse and drug-related crimes, drug screening is becoming an increasingly important part of healthcare
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773
The growth of the drug screening market is attributed to a number of factors. Firstly, the increasing prevalence of drug abuse and drug-related crimes is driving the demand for drug screening products. Furthermore, the increasing number of stringent government regulations and policies related to drug use is also driving the market growth. Moreover, the rising awareness of the health risks associated with drug abuse is also contributing to the growth of the drug screening market.
Key Market Players
The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Abbott Laboratories (US), Thermo Fisher Scientific (US), Quest Diagnostics (US), Alfa Scientific Designs (US), Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and Shimadzu (Japan). These companies are investing heavily in research and development to expand their product portfolios and gain a competitive edge in the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773
The study categorizes the Drug screening market into the following segments and subsegments:
By Product and Service
- Drug Screening Product
- Analytical Instruments
- Rapid Testing Devices
- Oral Fluid Testing Devices
- Consumables
- Drug Screening Service
By Sample Type
- Urine Samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
By End User
- Drug Testing Laboratories
- Workplaces
- Criminal Justice and Law Enforcement Agencies
- Hospitals
- Drug Treatment Centers
- Individual Users
- Pain Management Centers
- Schools and Colleges
By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Recent Developments
- Quest Diagnostics and Select Health of South Carolina entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees and to enhance access to diagnostics information services for members.
- LabCorp Entered into a multi-year agreement with Infirmary Health (US) to offer laboratory testing services in the eastern Gulf Coast.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162987773
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/drug-alcohol-screening-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/drug-alcohol-screening.asp
